4.6 Article

Phosphorylation of S6RP in peritubular capillaries of kidney grafts and circulating HLA donor-specific antibodies

Journal

FRONTIERS IN MEDICINE
Volume 9, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2022.988080

Keywords

transplantation-kidney; donor specific antibodies; mammalian target of rapamycin (mTOR); phosphorylation; peritubular capillaries; ribosomal protein S6 (S6RP); antibody mediated allograft rejection

Funding

  1. Instituto de Salud Carlos III (ISCIII)
  2. European Union [PI10/01370, PI13/00598, PI16/00617, PI PI20/00090]
  3. Sara Borrell Fellowship from Instituto de Salud Carlos III [RD12/0021/0024, RD16/0009/0013, 201822-10]
  4. Departament de Salut, Generalitat de Catalunya [CD17/00025]
  5. [PERIS SLT006/17/00040]

Ask authors/readers for more resources

Antibody-mediated rejection (ABMR) plays a significant role in allograft loss after kidney transplantation. This study investigates the activation of the mTOR pathway and its modulation by mTOR inhibitors in ABMR with donor-specific HLA-antibodies (DSA). The findings suggest different mechanisms of endothelial damage in ABMR + DSA+ and ABMR + DSA-.
Antibody-mediated rejection (ABMR) caused by donor-specific HLA-antibodies (DSA) is a mediator of allograft loss after kidney transplantation (KT). DSA can activate microvascular endothelium damage through the mTOR pathway. In this study we assessed the mTOR pathway activation by DSA in KT with ABMR (ABMR + DSA+) compared to controls (ABMR-DSA-), biopsies with ABMR changes without DSA (ABMR + DSA-) and DSA without ABMR changes (ABMR-DSA+), and the potential modulation by mTOR inhibitors (mTORi). We evaluated 97 biopsies: 31 ABMR + DSA+, 33 controls ABMR-DSA-, 16 ABMR + DSA-, and 17 ABMR-DSA+ cases. Regarding immunosuppression of full ABMR + DSA+ and controls, 21 biopsies were performed under mTORi treatment (11 of them ABMR + DSA+ cases) and 43 without mTORi (20 of them ABMR + DSA+) so as to explore its effect on the mTOR pathway. Biopsies were stained for C4d, Ki67, and phosphorylated (p) S6RP, ERK, and mTOR by immunohistochemistry. Labeling was graded according to peritubular capillary staining. ABMR biopsies showed significantly higher C4d, p-S6RP, and Ki67 staining in peritubular capillaries (PTC) compared to controls, and light differences in p-ERK or p-mTOR. mTORi treatment did not modify p-S6RP, p-mTOR, and p-ERK staining. Diffuse p-S6RP in PTC in the biopsies significantly associated with circulating HLA-DSA independently of graft rejection, and with worse death-censored graft survival. These findings suggest that activation of endothelium through the mTOR pathway evidence different mechanisms of damage in ABMR + DSA+ and ABMR + DSA- despite similar histological injury.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available